What the technology does
A simple biomarker signature for the diagnosis of TB from sputum samples, suitable for a lateral flow diagnostic test.
A specific and sensitive (96% correct classification) test that is stable, rapid, inexpensive and suitable for use at the point of care (i.e. in a non-laboratory setting).
Main application field
Ready for development with a suitable platform.
National phase applications in multiple territories, with a priority date of 18/09/2013 (PCT publication number WO15/040377)
Collaborative development and exclusive or non-exclusive licence